Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

INTRODUCTION: Percutaneous coronary intervention (PCI)-related myocardial infarction (type 4a MI) and major periprocedural myocardial injury have been demonstrated leading to poor prognosis of patients with coronary heart disease (CHD) undergoing elective PCI and still remain high occurrence even af...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zhuoshan, Zhuang, Xiaodong, Zhang, Shaozhao, Huang, Yiquan, Yuan, Lianxiong, Lin, Aiwen, Tang, Leile, Xiong, Zhenyu, Christopher, Odong, Chen, Yang, Wu, Bingyuan, Ling, Yesheng, Li, Suhua, Jie, Qiang, Xiong, Longgen, Qian, Xiaoxian, Liao, Xinxue, Liu, Jinlai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347504/
https://www.ncbi.nlm.nih.gov/pubmed/37433737
http://dx.doi.org/10.1136/bmjopen-2023-072541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347504/
https://www.ncbi.nlm.nih.gov/pubmed/37433737
http://dx.doi.org/10.1136/bmjopen-2023-072541

Ejemplares similares